Simulations Plus
Simulations Plus, Inc | Modeling & Simulation Software | Consulting Services for Pharmaceutical Research.
Launch date
Employees
Market cap
CAD879m
Enterprise valuation
CAD718m (Public information from Sep 2024)
Share price
$31.45 SLP
Lancaster California (HQ)
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 41.6m | 46.5m | 53.9m | 59.6m | 71.0m | 91.9m | 89.7m |
% growth | 22 % | 12 % | 16 % | 11 % | 19 % | 29 % | (2 %) |
EBITDA | 11.9m | 11.5m | 14.9m | 8.7m | 23.7m | 28.2m | - |
% EBITDA margin | 28 % | 25 % | 28 % | 15 % | 33 % | 31 % | - |
Profit | 9.3m | 9.8m | 12.5m | 10.0m | 13.3m | 16.6m | - |
% profit margin | 22 % | 21 % | 23 % | 17 % | 19 % | 18 % | - |
EV / revenue | 28.1x | 19.2x | 22.5x | 14.9x | 12.8x | 9.9x | 10.1x |
EV / EBITDA | 98.6x | 77.9x | 81.5x | 101.6x | 38.3x | 32.1x | - |
R&D budget | 3.0m | 4.0m | 3.2m | 4.5m | - | - | - |
R&D % of revenue | 7 % | 9 % | 6 % | 8 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $5.7m Valuation: $20.0m | IPO | |
N/A | N/A | - | |
N/A | Grant | ||
* | $1.7m | Grant | |
* | N/A | Grant | |
* | N/A | Grant | |
Total Funding | CAD2.3m |
Related Content
Recent News about Simulations Plus
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Simulations Plus
EditACQUISITION by Simulations Plus Jul 2014
ACQUISITION by Simulations Plus Jun 2023
ACQUISITION by Simulations Plus May 2017
ACQUISITION by Simulations Plus Apr 2020
ACQUISITION by Simulations Plus Jun 2024